Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market
Holding FULC?
Track your performance easily

Fulcrum Therapeutics (FULC) Ownership - Who Owns Fulcrum Therapeutics?

468 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
May 09, 2024
xxxxxxxxxxxxx
$1831
Mar 05, 2024
Alex Sapir
President & Ceo,director
xxxxxxxxxxxxx
$491702

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$117025
Jun 30, 2024
xxxxxxxxxxxxx
$3108066

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,609,704Institution18.61%106,460,986
2,955,163Institution4.74%27,098,845
2,945,626Institution4.72%27,011,390
2,439,610Institution3.91%22,371,224
1,938,655Institution3.11%17,777,466
1,591,836Institution2.55%14,597,136
803,125Institution1.29%7,364,656
637,510Institution1.02%5,845,967
506,092Institution0.81%4,640,864
501,301Institution0.80%4,596,930

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,439,610Institution3.91%22,371,224
1,938,655Institution3.11%17,777,466
1,591,836Institution2.55%14,597,136
637,510Institution1.02%5,845,967
506,092Institution0.81%4,640,864
494,547Institution0.79%4,534,996
201,959Institution0.32%1,851,964
185,492Institution0.30%1,700,962
141,311Institution0.23%1,295,822
137,307Institution0.22%1,259,105

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,852,255Institution2.97%17,188,926
1,663,417Institution2.67%15,253,534
783,293Institution1.26%7,268,959
465,000Institution0.75%4,264,050
427,880Institution0.69%3,923,660
338,125Institution0.54%3,100,606
336,110Institution0.54%3,082,129
243,706Institution0.39%2,261,592
236,227Institution0.38%2,166,202
144,668Institution0.23%1,326,606

FAQ

Who Owns Fulcrum Therapeutics (FULC)?
Currently, no data Available
What percentage of Fulcrum Therapeutics (FULC) stock is held by institutional investors?
Currently, no data Available
What percentage of Fulcrum Therapeutics (FULC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Fulcrum Therapeutics (FULC)?
Peter Kolchinsky owns the most shares of Fulcrum Therapeutics (FULC).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis